Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial
Prabal Mittal*, Rafael Gafoor, Zara Sayar, Maria Efthymiou, Ibrahim Tohidi-Esfahani, Stella Appiah-Cubi, Deepa J. Arachchillage, David Atkinson, Ekaterina Bordea, M. Jorge Cardoso, Emilia Caverly, Arvind Chandratheva, Marisa Chau, Nick Freemantle, Carolyn Gates, H. Rolf Ja¨ger, Arvind Kaul, Chris Mitchell, Hanh Nguyen, Bunis PackhamJaye Paskell, Jignesh P. Patel, Chris Round, Giovanni Sanna, Abbas Zaidi, David J. Werring, David Isenberg, Hannah Cohen
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial'. Together they form a unique fingerprint.